Search

Trading volume is notoriously low in July and August, and stocks rarely budge much as a result. Here’s how to navigate the summer months.

The best contrarian stocks often emerge from a place of serious, albeit temporary, scorn and ridicule. United Continental (UAL) is the most recent example.

The Trump Bump has been a boon to the stock market the last two months, but that doesn’t mean you should blindly expect the rally to continue.

Stock market results and the unemployment rate are historically intertwined. But that’s not the only reason stocks are near all-time highs right now.

My three-pronged value stock screener could come in handy in the coming years in a rising-interest-rate environment. Here’s how it works.

David Einhorn wants to create two classes of GM stock to stimulate growth. But Mr. Einhorn seems confused about what generates share price appreciation.

Video of a murder posted to Facebook was bad press for the social network. But it hasn’t done any damage to FB stock. Will it?

Coca-Cola stock has been dragging of late. But there’s a lot to like about this dividend stalwart, with plenty of opportunity for future growth.

Tyler Laundon, Chief Analyst of Cabot Small-Cap Confidential discussed a few promising stock trends during a Bloomberg LiveINSIGHTS webinar.

My stock pick today is a company that has done a great job of re-inventing itself, writing a new chapter in its story after a very successful first run.

The big problem is that the market has been going up for so long that people forget that it can go down.

The cannabis sector remains in a correction, with both marijuana and CBD stocks trending lower, giving up some of their early-year gains—and perhaps building a bottom here.

In the meantime, more and more peripheral companies are getting in on the action, and we have been increasing our exposure to these in recent weeks while still holding substantial cash.

This week we’re selling one more of the pure-play marijuana companies, raising the portfolio’s cash level to about 27%.

Full details in the issue.

The latest issue of Cabot Marijuana Investor is now available, with my current advice on the fourteen stocks in the portfolio.

The cannabis sector is currently in a correction, with both marijuana and CBD stocks trending lower, giving up some of their early-year gains—and perhaps building a bottom here.

In fact some of the biggest stocks, those supported best by institutional investors, are already looking stronger, though it will take time to know if they are in real uptrends. In the meantime, I continue to build cash, which will come in handy when it’s time to buy again.

Last week we sold a portion of three stocks and this week we’re selling portions of two more, raising the portfolio’s cash level to about 33%.

It was a good week despite the ongoing rumblings of oil-related debt defaults, talk of the perils of a negative interest rate environment and relatively lackluster growth from companies that have reported thus far.

I’ve steered clear of small caps that would have been heavily influenced by either a Trump or Clinton victory, so I don’t expect to make any moves in our current portfolio based solely on today’s results.

The market continues to perform well, with the market’s leading stocks outperforming the broad market indexes. These are good times, so enjoy them! But remember to guard against complacency; hundreds of earnings reports are about to flood Wall Street, and we’re sure that some leaders will fail, while others will soar. Thus, while the overall bull market shows no sign of ending, the next few weeks will be volatile. This week’s Top Ten contains another well-rounded batch of stocks, with a couple of biotech names highlighting the newfound strength in that sector. Another group that’s quietly improved has been the steel stocks, with Schnitzer Steel (SCHN) leading the way. The stock is in a mild pullback following a powerful breakout in recent weeks. We think it’s buyable around here.

Stock Name	Price	Buy Range	Loss Limit
TKC (TKC)	0.00	19-23	-
ALNY (ALNY)	0.00	30-35	-
AUXL (AUXL)	0.00	21-23	-
CIEN (CIEN)	0.00	44-46	-
FSLR (FSLR)	0.00	125-135	-
HANS (HANS)	0.00	56-60	-
OVTI (OVTI)	0.00	22-24	-
QMAR (QMAR)	0.00	19-22	-
RIMM (RIMM)	0.00	106-114	-
SCHN (SCHN)	0.00	65-70	-

Current Market Outlook


Two weeks ago we saw a bunch of positive earnings reactions that bolstered leading stocks, but last week was mostly the reverse—the leaders that had been running for months took on water, often reacting poorly to earnings and/or share offerings. Of course, while we see a few storm clouds, it’s not a hurricane, as the major indexes are in good shape and there are a growing number of “fresher” leaders (just getting going in the past few weeks) that are still acting just fine. All in all, the majority of the evidence is bullish, so we are as well, but it’s a stock-by-stock environment—many names look fine and are even buyable (preferably on weakness), but if you do have some extended stocks that are wobbling, have a plan in place (tightening stops, partial profits, etc.) in case the sellers gain strength.

This week’s list contains many of those fresher leaders mentioned above, including a few that have taken off on earnings. Our Top Pick is Zillow (Z), which should be a great bet to benefit from the new housing boom.

Stock Name	Price	Buy Range	Loss Limit
Agnico Eagle Mines (AEM)	79.05	79.5-82.5	71-73
Chart Industries (GTLS)	72.05	69-73	59-61
Digital Turbine (APPS)	24.75	21.5-24	17.5-19
Freeport-McMoRan Inc. (FCX)	13.78	13.3-14.5	11.5-11.9
Freshpet (FRPT)	107.99	99-102.5	89-91
LivePerson (LPSN)	58.55	55-58.5	47-49
Maxar Technologies (MAXR)	27.02	22-23.5	20-20.5
Ollie’s Bargain Outlet (OLLI)	103.94	100-103.5	91-93
Taiwan Semiconductor (TSM)	78.41	75-78	68-70
Zillow (Z)	76.64	77-80	67-68.5

Part of what makes turnaround mutual funds an inefficient and therefore profitable investing niche is that most investors avoid these securities. Managers of this small group of funds are comfortable with the contrarian approach of owning stocks that are avoided by more conventional mutual fund managers.

In this issue, we highlight seven of these turnaround-oriented mutual funds we’ve watched over the years.